ABVC BioPharma, Inc. (ABVC) News
Follow ABVC BioPharma, Inc. (ABVC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
ABVC BioPharma Closes $3.39 Million Convertible Note Placement
ABVC BioPharma closed a private placement of original issue discount senior convertible promissory notes for gross proceeds of $3.39 million.
EQUITY | Nov 02, 2026, 03:01 PM UTC
M
ABVC BioPharma Agrees to Sell $4.11 Million in Convertible Notes
ABVC BioPharma agreed to sell $4.11 million in principal amount of senior convertible notes for $3.39 million. Proceeds are intended for working capital, subsidiary funding and a payment to Lind. The company also reached
EQUITY | Nov 02, 2026, 02:53 PM UTC
H
ABVC Halts Pending News
ABVC trading halted pending news
EQUITY | Aug 03, 2026, 08:50 PM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Monday's pre-market session, with gains and losses across the sector
EQUITY | Jun 22, 2026, 12:08 PM UTC